TELL : +91 0 99 08 87 07 06

 Mcmed International ®: Largest Journal Publication in world

Acta Biomedica Scientia

Volume 4, Issue 3, 2017
Mcmed International
Acta Biomedica Scientia
Issn
2348 - 215X (Print), 2348 - 2168 (Online)
Frequency
bi-annual
Email
editorabs@mcmed.us
Journal Home page
http://mcmed.us/journal/abs
Recommend to
A Friend  | A librarian
Purchase
Purchase Issue
Abstract
Title
NEW SYSTEMIC THERAPY FOR METASTATIC MALIGNANCIES FOLLOWING PALLIATIVE RADIATION-THERAPY
Author
Dhileepan Kandasamy Thiyagarajan & 1S. Rajarajan
Email
dhileepan@outlook.com
keyword
Radiation-therapy, case, score
Abstract
The National Cancer Policy Board defines ordinary care as "where proven strategy practices are under utilised, proven unsuccessful practices are over utilized, and services of ambiguous effectiveness are used based on provider preference rather than case preference." Following at least two rounds of palliative radiation-therapy, develop a score system to aid in the decision for a new systemic therapy for metastatic tumor. In an exploratory prognostic study for overall survival, we looked at all the baseline parameters. womanhood, ovarian initial tumor site, and group A were all related with a better prognosis in univariate analysis, whereas age, past therapy response, and the number and kind of current therapy lines were not in a multivariate analysis. From 0% (death) to 100% of the score is given. The score has been used to predict survival with reasonable accuracy multiple times. PPS was also utilised in retrospective research to look at cases' performance before starting a new therapy cycle for advanced tumor. The small sample size and variability of the group in terms of original tumor types and number of previous radiation-therapy lines are the study's key limitations
Download Broucher
Back to Top >>>>